LOS ANGELES, Dec 21 (Reuters) - Johnson & Johnson and Schering-Plough Corp said on Friday their distribution agreement for rheumatoid arthritis treatment Remicade and golimumab, J&J's next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results